Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States
about
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell CarcinomaOral cavity and oropharyngeal squamous cell carcinoma--an updateIdentification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional studyGeographic trends of tobacco-related cancers in CyprusImmunology and Immunotherapy of Head and Neck CancerIncidence of tonsillar cancer in northern Sweden: Impact of human papilloma virusHuman papillomavirus genotype and oropharynx cancer survival in the United States of America.Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.Adults With Oral High-risk Human Papillomavirus (HPV) and/or Smoking History Have a Higher Risk for Clinically Diagnosed Oral Premalignant Lesions.Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.The cost of oropharyngeal cancer in England: A retrospective hospital data analysis.The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.Oropharyngeal cancer and human papilloma virus: evolving diagnostic and management paradigms.Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers.Novel Approaches for Vaccination Against HPV-Induced Cancers.Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.Human Papillomavirus-Related Oropharyngeal Cancer in Women.Recurrent respiratory papillomatosis in northern Sweden: clinical characteristics and practical guidance.Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.Emerging insights into recurrent and metastatic human papillomavirus‐related oropharyngeal squamous cell carcinoma.Courage Unmasked.Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.Five-year relative survival for human papillomavirus-associated cancer sites.
P2860
Q26782499-2415360F-E87F-4B44-8EC7-07E5DE6B131DQ26799210-1A8175A0-AB78-4740-A665-81262A9AEFB4Q35006526-76F9D2D5-54AE-4918-95D2-BFA5FF2C50C3Q35902892-D5AD60DF-8879-494E-951B-04FC2F7B86A4Q36100837-435CBFB3-3F63-463D-8466-0D3D09069F4AQ36336570-D1798EF8-DBC1-4643-A3E2-892F8692AED0Q36338604-A3D1D515-AEC0-479A-83FD-90E9D0229328Q36547246-779F1E51-8BF4-415F-9B5D-2827A248E8AFQ37059928-4BFD11C3-CD23-46C9-A3E7-2009C829BA50Q37255789-22F873AD-BB20-442D-8783-DDC6E8059530Q38583292-C926C45C-E975-42CF-BC80-6424EC343FA4Q38666893-FFEBC113-523E-43D6-A943-78135BE4D197Q38672321-9C4B6896-63B9-451F-A982-D8E5D7B0F1DAQ38674531-BB4411F7-CC13-49C2-9BF2-8EB4745066B5Q38723429-856416A8-CB1E-46E4-A38D-CD6A2E2372E0Q38846062-3F9D3ED5-69FB-4477-A1E7-0A2965B7CC28Q39033362-E8332BC7-A692-44B0-A42C-4F1B1887FA22Q40046181-EA5ADEDE-EC00-4E71-8843-1FD039A12A26Q40049755-74394D55-CE43-45D0-9B9E-28C3F54CFAACQ40375583-7C76F9E9-71BC-4FE2-8A62-56AA47FD8A17Q40421093-188A6CBA-B027-4A53-8502-63D5FE176A1FQ40750282-A0072410-81FE-4B65-8FA7-ABA307E9C70FQ40907706-0AEE9FAC-C341-4E06-8B1B-EC9D1682294CQ43168107-2D174967-1A83-4896-9B3F-7BDCD2D3DD52Q46699165-950345F7-60F1-4E74-9D49-A3429F346AE9Q46913137-DFC0BF5A-9F24-4EE2-9383-685DD4016956Q47407081-803FB1E4-F118-47BE-90E2-51F06417F42DQ47589931-EBDBF9CF-075A-4565-AF1A-D53120E56D40
P2860
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Human papillomavirus prevalenc ...... ne introduction, United States
@ast
Human papillomavirus prevalenc ...... ne introduction, United States
@en
Human papillomavirus prevalenc ...... e introduction, United States.
@nl
type
label
Human papillomavirus prevalenc ...... ne introduction, United States
@ast
Human papillomavirus prevalenc ...... ne introduction, United States
@en
Human papillomavirus prevalenc ...... e introduction, United States.
@nl
prefLabel
Human papillomavirus prevalenc ...... ne introduction, United States
@ast
Human papillomavirus prevalenc ...... ne introduction, United States
@en
Human papillomavirus prevalenc ...... e introduction, United States.
@nl
P2093
P2860
P356
P1476
Human papillomavirus prevalenc ...... ne introduction, United States
@en
P2093
Brenda Y Hernandez
Charles F Lynch
Christopher Lyu
Claudia Hopenhayn
Edward J Wilkinson
Glen Copeland
HPV Typing of Cancers Workgroup
Jennifer L Cleveland
Marc T Goodman
Maria S Saber
P2860
P304
P356
10.3201/EID2005.131311
P577
2014-05-01T00:00:00Z